Brighton and Sussex Medical School
Brighton and Hove
,United Kingdom
Program Name
PhD in Acute Myeloid Leukaemia (Aml)
Deadline
January 30th, 2026
Overview
Applications are invited for a 3-year funded PhD studentship at Brighton and Sussex Medical School. Project details. Acute Myeloid Leukaemia (AML) is a highly aggressive blood cancer characterised by the accumulation of immature myeloid cells in the bone marrow.
Duration
3 Months
Ranking
#201
The World University Rankings
Class Profile
Application Requirements
Here's everything you need to know to ensure a complete and competitive application—covering the key documents and criteria for a successful submission.
Application Deadlines
| Default | |
|---|---|
| winter | Jan 30, 2026 |
Ready to elevate your study abroad journey?
Book a call with us now and take the first step towards your global future!
Connect with us on our social media
